Products
Platform
Research
Market
Learn
Compare WhiteOak Capital Pharma and Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.38 | 1.87 |
NAV | ₹14.03 | ₹40.45 |
Fund Started | 16 Jan 2024 | 25 Jun 2018 |
Fund Size | ₹442.67 Cr | ₹6226.82 Cr |
Exit Load | Exit load of 1%, if redeemed within 1 months. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.38
1.87
NAV
₹14.03
₹40.45
Fund Started
16 Jan 2024
25 Jun 2018
Fund Size
₹442.67 Cr
₹6226.82 Cr
Exit Load
Exit load of 1%, if redeemed within 1 months.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 7.65% | 4.06% |
3 Year | - | 27.90% |
5 Year | - | 20.00% |
1 Year
7.65%
4.06%
3 Year
-
27.90%
5 Year
-
20.00%
Holding Analysis
Equity | 98.42% | 97.55% |
Cash | -10.33% | 2.45% |
Equity
98.42%
97.55%
Cash
-10.33%
2.45%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
JB Chemicals & Pharmaceuticals Ltd. | 6.94% |
Sun Pharmaceutical Industries Ltd. | 6.81% |
Fortis Healthcare Ltd. | 6.69% |
Cipla Ltd. | 4.56% |
Laurus Labs Ltd. | 4.28% |
Krishna Institute of Medical Sciences Ltd | 4.09% |
Neuland Laboratories Ltd. | 3.20% |
Max Healthcare Institute Ltd. | 3.19% |
Sun Pharmaceutical Industries Ltd. | 3.15% |
Lupin Ltd. | 3.14% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.58% |
Dr. Reddy's Laboratories Ltd. | 9.10% |
Divi's Laboratories Ltd. | 8.75% |
Aurobindo Pharma Ltd. | 8.25% |
Cipla Ltd. | 6.92% |
Lupin Ltd. | 5.43% |
Alkem Laboratories Ltd. | 4.05% |
Biocon Ltd. | 3.11% |
Gland Pharma Ltd. | 2.97% |
Mankind Pharma Ltd. | 2.95% |
Fund Manager
Name | Trupti Agrawal | Dharmesh Kakkad |
Start Date | 15 May 2024 | 23 Feb 2021 |
Name
Trupti Agrawal
Dharmesh Kakkad
Start Date
15 May 2024
23 Feb 2021
About Fund
Description | The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 16 Jan 2024 | 25 Jun 2018 |
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
16 Jan 2024
25 Jun 2018